Jefferies Keeps Lowest Rating on Arena Pharma (ARNA) After Q4 Call and Into May Lorcaserin Panel
Go back to Jefferies Keeps Lowest Rating on Arena Pharma (ARNA) After Q4 Call and Into May Lorcaserin Panel| Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) | Delayed: 99.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.98 | 52 Week High | $2.68 | |||
| Open | $0.14 | 52 Week Low | $1.30 | |||
| Day High | $99.98 | P/E | N/A | |||
| Day Low | $99.98 | EPS | $-0.08 | |||
| Volume | 21,430 | |||||
